JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors

Sponsor
University Hospital Heidelberg
Study ID
NCT06621277
Status
Recruiting
Apply to this trial

Conditions

  • Gastrointestinal Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No intervention — OTHER
    No intervention
  • Tailored counseling programs (Phase 2) — OTHER
    Optimized care services and tailored counseling programs for young patients with GI tumors at the Heidelberg University Hospital (Phase 2)

Study Details

JUMP\_START aims to assess the needs of individuals aged ≤ 50 years with gastrointestinal (GI) tumors and implement a tailored support and counseling program at the University Hospital Heidelberg and the National Center for Tumor Diseases (NCT). In phase 1A, 12-15 individuals aged ≤ 50 years with GI tumors will be interviewed via telephone using semi-structured interviews to obstain a detailed understanding of the life situation, the burdens, and the care situation within the structures of the NCT Heidelberg. In phase 1B, the care networks of young patients with GI tumors beyond the NCT, including the analysis of changes and important access routes/possible gatekeepers, will be explored using so-called ego-centered network analyses, in comparison with patients who received a GI tumor diagnosis after the age of 50. In response to the results of phase 1A and 1B, the care services for young patients with GI tumors will be optimized, and tailored counseling programs will be developed in phase 2. These project phases will be accompanied by Quality of Life assessments using European Organisation for Research and Treatment of Cancer (EORTC) questionnaires. All patients with GI tumors (regardless of potential inclusion in phase 1A or 1B) will receive the EORTC questionnaires once. In phase 2, Quality of Life will be assessed every 6 months.

Key Dates

First listed
Oct 1, 2024
Start date
Oct 1, 2023
Status verified
Sep 2024
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
250 participants (estimated)

Arms

  • Arm: Individuals received a GI tumor diagnosis > 50 years
  • Arm: Individuals received a GI tumor diagnosis ≤ 50 years

Primary Outcome Measure

Change from baseline in Quality of Life at two years [ Time Frame: Baseline, 6; 12; 18, and 24 months ]

Central Contacts

Related Studies